![Svetlana Lucas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Svetlana Lucas
Director/Board Member at
ATYR PHARMA, INC.
Net worth: 12 002 $ as of 2026-06-29
Profile
Dr. Svetlana Lucas is an Independent Director at Jasper Therapeutics, Inc., an Independent Director at aTyr Pharma, Inc. and a Chief Business Officer at Scribe Therapeutics, Inc. She is on the Board of Directors at Jasper Therapeutics, Inc. and aTyr Pharma, Inc. Dr. Lucas was previously employed as a Senior Vice President-Business Development by Tizona Therapeutics, Inc. and a Head-Oncology & Inflammation by Amgen, Inc. She received her undergraduate degree from Moscow State University Lomonosov and a doctorate degree from California Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-31 | 20,000 ( 0.07% ) | 8 420 $ | 2026-06-29 | |
ATYR PHARMA, INC. 0.01% | 2026-05-10 | 6,000 ( 0.01% ) | 3 582 $ | 2026-06-29 |
Svetlana Lucas active positions
| Companies | Position | Start |
|---|---|---|
| ATYR PHARMA, INC. | Director/Board Member | 2019-06-27 |
| JASPER THERAPEUTICS, INC. | Director/Board Member | 2024-06-18 |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Corporate Officer/Principal | 2019-05-31 |
Former positions of Svetlana Lucas
| Companies | Position | End |
|---|---|---|
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Corporate Officer/Principal | 2018-12-31 |
| AMGEN INC. | Corporate Officer/Principal | 2015-06-30 |
Training of Svetlana Lucas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moscow State University Lomonosov
 Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
- Stock Market
- Insiders
- Svetlana Lucas
Choose MarketScreener 
